This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw XML (canonical form + also see XML Format Specification)
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped (id = "meddisp0317")
<?xml version="1.0" encoding="UTF-8"?> <MedicationDispense xmlns="http://hl7.org/fhir"> <id value="meddisp0317"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: MedicationDispense</b> <a name="meddisp0317"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationDispense "meddisp0317" </p> </div> <p> <b> status</b> : stopped</p> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <span title=" Linked to a RESOURCE Medication "><a name="med0306"> </a> </span> <blockquote> <p/> <p> <a name="med0306"> </a> </p> <p> <b> code</b> : Adcetris (Brentuximab Vedotin 50mg/10.5ml) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-ndc.html">National drug codes</a> #51144-050-01)</span> </p> <p> <b> marketingAuthorizationHolder</b> : <a href="organization-example-mmanu.html">Organization/mmanu</a> "Acme Corporation"</p> <p> <b> doseForm</b> : Lyophilized powder for injectable solution (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #421637006)</span> </p> </blockquote> </td> </tr> </table> <p> <b> subject</b> : <a href="patient-example-a.html">Patient/pat1: Donald Duck </a> "Donald DUCK"</p> <h3> Performers</h3> <table class="grid"><tr> <td> -</td> <td> <b> Actor</b> </td> </tr> <tr> <td> *</td> <td> <a href="practitioner-example-f006-rvdb.html">Practitioner/f006</a> "Rob VAN DEN BERK"</td> </tr> </table> <p> <b> authorizingPrescription</b> : <a href="medicationrequest0316.html">MedicationRequest/medrx0316</a> </p> <p> <b> type</b> : Trial Fill <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-ActCode.html">ActCode</a> #TF)</span> </p> <p> <b> quantity</b> : 3(unit 415818005 from http://snomed.info/sct)<span style="background: LightGoldenRodYellow"> (Details: SNOMED CT code 415818005 = '415818005')</span> </p> <p> <b> daysSupply</b> : 1 Day<span style="background: LightGoldenRodYellow"> (Details: UCUM code d = 'd')</span> </p> <p> <b> whenPrepared</b> : 2015-06-25T07:13:00+05:00</p> <p> <b> whenHandedOver</b> : 2015-06-26T07:13:00+05:00</p> <blockquote> <p> <b> dosageInstruction</b> </p> <p> <b> sequence</b> : 1</p> <p> <b> text</b> : 1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles</p> <p> <b> timing</b> : Count 16 times, Once per 3 weeks</p> <p> <b> route</b> : Intravenous <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #255560000)</span> </p> <blockquote> <p> <b> doseAndRate</b> </p> </blockquote> </blockquote> </div> </text> <contained> <Medication> <id value="med0306"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="51144-050-01"/> <display value="Adcetris (Brentuximab Vedotin 50mg/10.5ml)"/> </coding> </code> <marketingAuthorizationHolder> <reference value="Organization/mmanu"/> </marketingAuthorizationHolder> <doseForm> <coding> <system value="http://snomed.info/sct"/> <code value="421637006"/> <display value="Lyophilized powder for injectable solution (qualifier value) "/> </coding> </doseForm> </Medication> </contained> <status value="stopped"/> <medication> <!-- Linked to a RESOURCE Medication --> <reference> <reference value="#med0306"/> <display value="Brentixumab Vedotin (Adcetris)"/> </reference> </medication> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck "/> </subject> <performer> <actor> <reference value="Practitioner/f006"/> </actor> </performer> <authorizingPrescription> <reference value="MedicationRequest/medrx0316"/> </authorizingPrescription> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> <code value="TF"/> <display value="Trial Fill"/> </coding> </type> <quantity> <value value="3"/> <system value="http://snomed.info/sct"/> <code value="415818005"/> </quantity> <daysSupply> <value value="1"/> <unit value="Day"/> <system value="http://unitsofmeasure.org"/> <code value="d"/> </daysSupply> <whenPrepared value="2015-06-25T07:13:00+05:00"/> <whenHandedOver value="2015-06-26T07:13:00+05:00"/> <dosageInstruction> <sequence value="1"/> <text value="1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles"/> <timing> <repeat> <count value="16"/> <frequency value="1"/> <period value="3"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="255560000"/> <display value="Intravenous"/> </coding> </route> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="1.8"/> <unit value="mg/kg"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </doseQuantity> </doseAndRate> </dosageInstruction> </MedicationDispense>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 hl7.fhir.core#5.0.0 generated on Sun, Mar 26, 2023 15:25+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R4B |
|
Propose a change